Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes

NCT01536028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 50
DRUG: biphasic insulin aspart 70
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S